Biomea Fusion Inc. (BMEA) stock
Price, quality score, analyst targets, a 30-day Kronos AI forecast and a Shariah screen for Biomea Fusion Inc., updated every trading day.
Health Care · Biotechnology: Pharmaceutical Preparations
Price
$0.65
+0.83% today
Market cap
$47M
Overall quality
46/100
Kronos AI 30-day
—
Biomea Fusion Inc. (BMEA) is a Health Care company in Biotechnology: Pharmaceutical Preparations, worth $47M. It trades at $0.65, up 0.83% today. Its overall quality score is 46 out of 100, ranked against the whole US market. 6 analysts' average target of $7.33 implies +1027.7% from today's price.
Open the full interactive analysis →Charts, technical signals, DCF fair value and ownership
Analyst price targets
| Average target | $7.33 |
| Low – high | $4.00 – $10.00 |
| Analysts | 6 |
| Upside to average | +1027.7% |
Kronos AI 30-day forecast
No forecast for this listing.
Quality scores
| Profitability | 36 |
| Solvency | 56 |
| Growth | 46 |
| Overall | 46 |
| P/E | — |
Shariah screen
| Business activity | Passes |
| Debt and cash (AAOIFI 30%) | Not checked for this listing |
Automated screen of business activity and AAOIFI's 30% debt and cash limits. The 5% impermissible-income test is not applied. Check with a scholar before deciding.
Halal Health Care stocks · Zakat calculator · Purification calculator
Similar companies in Biotechnology: Pharmaceutical Preparations
For information only, not investment advice. Prices updated: 2026-10-29.